Research & Validation
A competitor has a similar patent — what does that mean for me?
The short answer
Usually less than you fear. Research on patent strategy found 17% of patents are held at least partly for preemption — blocking competitors — but only 3% are purely preemptive. Overlapping patents typically signal a shared, validated market and a race to license, not a dead end.
The full picture
First, check the overlap precisely: similar titles mean nothing; claims are everything. Their patent may cover a different embodiment, a different application, or a narrower slice than yours. Reading the actual independent claims side by side — ideally with professional help — usually shrinks the scary overlap to a specific boundary question.
Commercially, a competitor's patent can help you: it validates the market, it may cite you (strengthening your visibility), and cross-licensing is a normal endgame when two players hold blocking positions. The scenario that genuinely needs strategy is mutual blocking — and even that is usually a negotiation, not a war. Worth mapping your exact position before assuming the worst.
Where does your patent stand?
The Beyond the Patent Commercialization Score answers that — a professional, factor-by-factor read on your patent's licensing, sale, build, and partner potential.
Related questions
General information for patent owners — not legal advice. Read the disclaimer.
